Skip to main content
. 2020 Aug 24;20(5):149. doi: 10.3892/ol.2020.12012

Figure 4.

Figure 4.

Clinical value analysis of Models 1 and 2. (A) Time-dependent receiver operating characteristic curve analysis of prediction model. (B) Decision curve analysis for Model 1 and Model 2 in prediction of DFS of TNBC at the 3-year point. Model 1 consisted of N stage and NAC. Model 2 consisted of N stage, NAC and EDNRB expression. DFS, disease-free survival; TNBC, triple-negative breast cancer; N, lymph node; NAC, neoadjuvant chemotherapy.